Novavax’s latecomer Covid-19 vaccine gets U.S. authorization.
The Food and Drug Administration on Wednesday authorized a COVID-19 vaccine developed by Novavax, a biotechnology company in Maryland that received significant federal funding to produce the shot. Vaccines will be a new option for Americans as vaccination rates remain stable. After two years of development, the vaccine has finally overcome manufacturing problems and has … Read more